CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,230,845
- in 7 filings, $1.6M under 10b5-1 plans
Net −$2,230,845. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-12 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −3,000 | $25.07 | $75K | 0 |
| 2024-07-12 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 209,620 | ||
| 2024-07-01 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −12,000 | $22.89 | $275K | 1,105,035 |
| 2024-06-27 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +4,250 | $2.48 | $11K | 4,250 |
| 2024-06-27 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,280 | $21.79 | $28K | 2,970 |
| 2024-06-27 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,830 | $22.58 | $41K | 1,140 |
| 2024-06-27 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,140 | $23.43 | $27K | 0 |
| 2024-06-27 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −4,250 | 212,620 | ||
| 2024-06-25 | Kintz Samuel PRESIDENT AND CEO | Sale 10b5-1 | −11,422 | $21.63 | $247K | 1,076,103 |
| 2024-06-25 | Kintz Samuel PRESIDENT AND CEO | Sale 10b5-1 | −578 | $22.30 | $13K | 1,075,525 |
| 2024-06-17 | Heyman Richard A. Director | Sale 10b5-1 | −1,270 | $21.48 | $27K | 134,615 |
| 2024-06-06 | Patel Anish CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +1,133 | $2.48 | $3K | 1,133 |
| 2024-06-06 | Patel Anish CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,133 | $20.06 | $23K | 0 |
| 2024-06-06 | Patel Anish CHIEF OPERATING OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −1,133 | 53,342 | ||
| 2024-05-29 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +12,000 | $1.12 | $13K | 12,000 |
| 2024-05-29 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −9,877 | $21.56 | $213K | 2,123 |
| 2024-05-29 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale 10b5-1 | −2,123 | $22.52 | $48K | 0 |
| 2024-05-29 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −12,000 | 206,550 | ||
| 2024-05-28 | Kintz Samuel PRESIDENT AND CEO | Option exercise 10b5-1 | +12,000 | $1.12 | $13K | 12,000 |
| 2024-05-28 | Kintz Samuel PRESIDENT AND CEO | Sale 10b5-1 | −6,681 | $22.86 | $153K | 5,319 |
Page 19 of 37 · 724 trades